STADA Acquires GSK’s Consumer Healthcare Portfolio to Expand its OTC Business

Shots:

• STADA to acquire GSK’s 15 well-established consumer healthcare brands including Venoruton, for venous treatment, Coldrex cold remedy, Cetebe vitamin C supplements, Mebucaine sore throat range and Tavegyl allergy brand
• The acquisition will strengthen STADA’s OTC portfolio and accelerates its growth in European countries. The transaction is expected to be completed in Q2’2020
• The acquisition follows STADA’s acquisition of GSK’s five OTC skincare brands-Ceridal, Eurax, Oilatum, Polytar, Savlon and pediatric cough remedies, Tixylix in EU and selected markets in the Asia-Pacific and Latin America regions

Click here ­to­ read full press release/ article | Ref: STADA | Image: Reuters